“…9,10 Accordingly, there remains a focus on aliphatic polyesters for pharmaceutical applications, as there are many flexible routes for their synthesis, and the metabolites produced upon their breakdown in the body are largely known and are removed via natural excretory pathways. [11][12][13] Poly(lactide)s (PDLLA), poly(caprolactone)s (PCL) and poly(glycolide)s (PGA) and their copolymers are the most widely used polyesters in the health care sector, owing to their accessibility from readily-available monomers, favourable mechanical properties, hydrolytic degradation and biocompatibility. [14][15][16][17] Of particular interest are poly(lactide)s and associated copolymers which can be easily synthesised via ROP of D,L-lactide (LA), a natural recurring cyclic ester.…”